** Shares of Australian biopharmaceutical co Immuron Ltd
IMC.AX rise as much as 13.3% to A$0.085 in their biggest
intraday pct gain since Sept. 13
** IMC hits its highest level since Sept. 13
** Co says sales of Travelan, its digestive health immune
supplement, increased to a record A$1.3 mln ($835,770) in the
first quarter vs A$25,565 in Q1 FY23
** Anticipates continued demand for replenishment of
Travelan, as retail pharmacies sell to consumers - IMC
** Nearly 189,200 shares change hands by 0253 GMT, vs 30-day
average volume of 59,912
** Stock down 12.8% YTD, as of last close
($1 = 1.5555 Australian dollars)
(Reporting by Roshan Thomas in Bengaluru)
((Roshan.Thomas@thomsonreuters.com;))